Journal of Hepatology
Volume 56, Issue 2 , Pages 419-425, February 2012

Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish

  • Zhen Li

      Affiliations

    • Department of Biological Sciences, National University of Singapore, Singapore
  • ,
  • Xiaoqian Huang

      Affiliations

    • Department of Biological Sciences, National University of Singapore, Singapore
  • ,
  • Huiqing Zhan

      Affiliations

    • Department of Biological Sciences, National University of Singapore, Singapore
  • ,
  • Zhiqiang Zeng

      Affiliations

    • Department of Biological Sciences, National University of Singapore, Singapore
  • ,
  • Caixia Li

      Affiliations

    • Department of Biological Sciences, National University of Singapore, Singapore
  • ,
  • Jan M. Spitsbergen

      Affiliations

    • Department of Microbiology and Marine and Freshwater Biomedical Sciences Center, Oregon State University, Corvallis, OR, USA
  • ,
  • Svenja Meierjohann

      Affiliations

    • Physiologische Chemie I, Biocenter, University of Würzburg, Germany
  • ,
  • Manfred Schartl

      Affiliations

    • Physiologische Chemie I, Biocenter, University of Würzburg, Germany
  • ,
  • Zhiyuan Gong

      Affiliations

    • Department of Biological Sciences, National University of Singapore, Singapore
    • Corresponding Author InformationCorresponding author. Address: Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore. Tel.: +65 65162860; fax: +65 67792486.

Received 25 February 2011; received in revised form 24 June 2011; accepted 16 July 2011. published online 02 September 2011.

Background & Aims

Liver cancer, mainly hepatocellular carcinoma, is a major malignancy and currently there are no effective treatment protocols due to insufficient understanding of hepatocarcinogenesis. As a potentially high-throughput and cost-effective experimental model, the zebrafish is increasingly recognized for disease studies. Here, we aim at using the zebrafish to generate a convenient hepatocellular carcinoma model.

Methods

Using the Tet-on system for liver-specific expression of fish oncogene xmrk, a hyperactive version of epidermal growth factor receptor homolog, we have generated transgenic zebrafish with inducible development of liver cancer.

Results

Liver tumors were rapidly induced with 100% penetrance in both juvenile and adult xmrk transgenic fish. Histological examination indicated that they all showed features of hepatocellular carcinoma. The induced liver tumors regressed rapidly upon inducer withdrawal. During the tumor induction stage, we detected increased cell proliferation and activation of Xmrk downstream targets Erk and Stat5, which were important for liver tumorigenesis as proved by inhibition experiments. When tumors regressed, there were decreased phosphorylated Erk and Stat5 accompanied with an increase in apoptosis.

Conclusions

Our zebrafish model demonstrates the potential of a hyperactivated epidermal growth factor receptor pathway in initiating heptocarcinogenesis. It provides clear evidence for the requirement of only a single oncogene for HCC initiation and maintenance and is thus a convenient model for further investigation of oncogene addiction and future anti-cancer drug screening.

Abbreviations: HCC, hepatocellular carcinoma, TRE, tetracycline responsive element, EGFR, epidermal growth factor receptor, GFP, green fluorescent protein, RT-PCR, reverse transcriptase-polymerisation chain reaction, WISH, whole-mount in situ hybridization, H&E, hematoxylin and eosin, hpf, hour postfertilization, wpt, week post treatment-initiation, mpf, month postfertilization, HCA, hepatocellular adenoma

Keywords: Liver, EGFR, Cancer, Tumor regression

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8278(11)00660-X

doi:10.1016/j.jhep.2011.07.025

Journal of Hepatology
Volume 56, Issue 2 , Pages 419-425, February 2012